Company reviews goals and significance of the study and outlines development strategy in Mild Cognitive Impairment due to Alzheimer’s diseaseROCHESTER,...
Company focused on execution of lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) GRI-0621 interim data readout...
PEMGARDA™ launched commercially in Q2 2024 with $2.3 million of net product revenueNotable acceleration of commercial results in early Q3...
WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing...
Initiated Phase 2b trial of VYN201 in nonsegmental vitiligo, with top-line results expected in mid-2025Phase 1a SAD/MAD trial of VYN202...
Applauds first FDA approval of non-injection-based epinephrine deviceReiterates expected timing for filing of New Drug Application (NDA) for Anaphylm™ (epinephrine)...
Denifanstat Phase 2b FASCINATE-2 clinical trial 52-week data was presented in June at the European Association for the Study of...
Dr. Capon will present Hinge Bio’s innovative GEM-DIMER™ platform as an invited speaker at the “Pioneering Technology” Session at Trinity College,...
Company Anticipates Significant Sequential Growth in Quarterly Revenues Beginning in Q3 2024 and Beyond Reports Pharmaloz Growth Acceleration Has Begun...
LOS ANGELES, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Greyhound Chromatography and...
– Topline data from 1-year open-label extension (OLE) trial expected Q4 2024 – – Registrational RECOVER-2 trial in schizophrenia expected to...
- Reports YCANTH® revenue, net of $4.9M for second quarter of 2024 along with the expansion of YCANTH’s distribution footprint...
Softness in market for Shared R&D Services, with H1 2024 revenues down 7% year-on-year. Continued growth of sales order book...
VANCOUVER, BC / ACCESSWIRE / August 13, 2024 / Verisante Technology, Inc. (TSX-V:VER.H) ("Verisante") is pleased to announce that it...
Mitro Named President & Chief Executive Officer, Readies Pro-ocular™ for Phase 3 Trials The company's breakthrough drug is the first...
NORWALK, Conn., Aug. 13, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leading North American distributor of specialty chemicals and ingredients,...
RED WING, Minn., Aug. 13, 2024 /PRNewswire/ -- CRL Solutions is pleased to announce the appointment of Tru-Motion Products LLC...
$2.1M invested in seven companies to advance innovations from lab to market in Maryland COLUMBIA, Md., Aug. 13, 2024 /PRNewswire/...
Clario integrates Mobilise-D's algorithms into Clario's Opal®️ wearable sensor system to enable real-world mobility assessments that generate accurate and reliable...
NEW YORK, Aug. 13, 2024 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,...